Ralph Stadhouders

31PUBLICATIONS
165CO-AUTHORS
Tumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Environmentally sustainable engineeringEpidemiological methodsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Sep 10, 2026
PLA2G2D in tumour-draining lymph nodes regulates anti-tumour immunity.

|Aug 31, 2026
Neutralizing the IL-12/IL-23 p40 subunit prevents immune checkpoint blockade toxicity without compromising antitumor efficacy.

|May 01, 2026
Foxp3: The epigenetic engineer of regulatory T cell identity.

|Mar 14, 2026
Improving Lung Cancer Screening Selection: A Comparative Analysis of Risk Models and Traditional Criteria in a Western European General Population.

Danrong Zhong, Grigory Sidorenkov, Marcel J W Greuter

|Nov 28, 2025
REACtiVe-2: phase I evaluation of dendritic cell vaccination and agonistic CD40 therapy following (m)FOLFIRINOX in metastatic pancreatic cancer.

Songul Kucukcelebi, Freek R van 't Land, Sjoerd H van der Burg

|Jul 31, 2025
Epigenetic priming as a driver of memory recall and dysfunction in T cells.

Mieke Metzemaekers, Niels J Rinzema, Ralph Stadhouders

Pageof 6

Frequent Collaborators

6 joint publications

Rudi W Hendriks

5 joint publications

Gert-Jan Braunstahl

5 joint publications

Wilfred van Ijcken

5 joint publications

Thomas Graf